Published in J Virol on March 28, 2016
Chikungunya virus: epidemiology, replication, disease mechanisms, and prospective intervention strategies. J Clin Invest (2017) 0.89
Ribosomal frameshifting and transcriptional slippage: From genetic steganography and cryptography to adventitious use. Nucleic Acids Res (2016) 0.82
Palmitoylation of Sindbis virus TF protein regulates its plasma membrane localization and subsequent incorporation into virions. J Virol (2016) 0.75
Mutation of the N-Terminal Region of Chikungunya Virus Capsid Protein: Implications for Vaccine Design. MBio (2017) 0.75
Ablation of programmed -1 ribosomal frameshifting in Venezuelan equine encephalitis virus results in attenuated neuropathogenicity. J Virol (2016) 0.75
The alphaviruses: gene expression, replication, and evolution. Microbiol Rev (1994) 16.68
In vitro mutagenesis of a full-length cDNA clone of Semliki Forest virus: the small 6,000-molecular-weight membrane protein modulates virus release. J Virol (1991) 6.02
Combining the polymerase incomplete primer extension method for cloning and mutagenesis with microscreening to accelerate structural genomics efforts. Proteins (2008) 3.29
Infectious RNA transcripts from Ross River virus cDNA clones and the construction and characterization of defined chimeras with Sindbis virus. Virology (1991) 2.57
Internally located cleavable signal sequences direct the formation of Semliki Forest virus membrane proteins from a polyprotein precursor. J Virol (1991) 2.17
Chikungunya virus arthritis in adult wild-type mice. J Virol (2010) 2.16
Modification of membrane permeability by animal viruses. Adv Virus Res (1995) 2.11
Ross River virus transmission, infection, and disease: a cross-disciplinary review. Clin Microbiol Rev (2001) 2.00
Ross River virus: ecology and distribution. Annu Rev Entomol (2002) 1.65
Broadly Neutralizing Alphavirus Antibodies Bind an Epitope on E2 and Inhibit Entry and Egress. Cell (2015) 1.58
Inhibition of Sindbis virus production by media of low ionic strength: intracellular events and requirements for reversal. J Virol (1970) 1.49
Macrophage-derived proinflammatory factors contribute to the development of arthritis and myositis after infection with an arthrogenic alphavirus. J Infect Dis (2008) 1.48
A novel quantitative flow cytometry-based assay for autophagy. Autophagy (2010) 1.46
The Sindbis virus 6K protein can be detected in virions and is acylated with fatty acids. Virology (1990) 1.44
Discovery of frameshifting in Alphavirus 6K resolves a 20-year enigma. Virol J (2008) 1.33
Interactions between PE2, E1, and 6K required for assembly of alphaviruses studied with chimeric viruses. J Virol (1996) 1.33
Attenuation of Chikungunya virus vaccine strain 181/clone 25 is determined by two amino acid substitutions in the E2 envelope glycoprotein. J Virol (2012) 1.31
The inhibition of cell functions after viral infection. A proposed general mechanism. FEBS Lett (1977) 1.27
The 6-kilodalton membrane protein of Semliki Forest virus is involved in the budding process. J Virol (1995) 1.26
Semliki Forest virus 6K protein modifies membrane permeability after inducible expression in Escherichia coli cells. J Biol Chem (1994) 1.21
Macrophage-induced muscle pathology results in morbidity and mortality for Ross River virus-infected mice. J Infect Dis (2000) 1.20
Fate of the 6K membrane protein of Semliki Forest virus during virus assembly. Virology (1991) 1.20
Novel attenuated Chikungunya vaccine candidates elicit protective immunity in C57BL/6 mice. J Virol (2013) 1.19
Alphavirus 6K proteins form ion channels. J Biol Chem (2002) 1.10
Characterization of a small, nonstructural viral polypeptide present late during infection of BHK cells by Semliki Forest virus. J Virol (1980) 1.09
Ross River virus envelope glycans contribute to type I interferon production in myeloid dendritic cells. J Virol (2008) 1.02
Frameshifting in alphaviruses: a diversity of 3' stimulatory structures. J Mol Biol (2010) 0.96
The Semliki Forest virus E2 gene as a virulence determinant. J Gen Virol (1995) 0.94
Sindbis virus variant with a deletion in the 6K gene shows defects in glycoprotein processing and trafficking: lack of complementation by a wild-type 6K gene in trans. J Virol (2001) 0.93
Semliki Forest virus produced in the absence of the 6K protein has an altered spike structure as revealed by decreased membrane fusion capacity. Virology (2004) 0.93
Accumulation of autophagosomes in Semliki Forest virus-infected cells is dependent on expression of the viral glycoproteins. J Virol (2012) 0.88
Functional characterization of the alphavirus TF protein. J Virol (2013) 0.86
The alphavirus 6K protein activates endogenous ionic conductances when expressed in Xenopus oocytes. J Membr Biol (2007) 0.86
Cell permeabilization by poliovirus 2B viroporin triggers bystander permeabilization in neighbouring cells through a mechanism involving gap junctions. Cell Microbiol (2010) 0.85
A 6K-deletion variant of salmonid alphavirus is non-viable but can be rescued through RNA recombination. PLoS One (2014) 0.79
Wolbachia Blocks Viral Genome Replication Early in Infection without a Transcriptional Response by the Endosymbiont or Host Small RNA Pathways. PLoS Pathog (2016) 1.48
Unique epitopes recognized by antibodies induced in Chikungunya virus-infected non-human primates: implications for the study of immunopathology and vaccine development. PLoS One (2014) 0.97
Characterization of Aedes aegypti innate-immune pathways that limit Chikungunya virus replication. PLoS Negl Trop Dis (2014) 0.94
Antiviral activity of silymarin against chikungunya virus. Sci Rep (2015) 0.93
Prime-boost immunization strategies against Chikungunya virus. J Virol (2014) 0.92
Stress granule components G3BP1 and G3BP2 play a proviral role early in Chikungunya virus replication. J Virol (2015) 0.91
Inactivation of the type I interferon pathway reveals long double-stranded RNA-mediated RNA interference in mammalian cells. EMBO J (2016) 0.89
Bindarit, an inhibitor of monocyte chemotactic protein synthesis, protects against bone loss induced by chikungunya virus infection. J Virol (2014) 0.86
Viral Polymerase-Helicase Complexes Regulate Replication Fidelity To Overcome Intracellular Nucleotide Depletion. J Virol (2015) 0.82
Chikungunya virus: an update on the biology and pathogenesis of this emerging pathogen. Lancet Infect Dis (2017) 0.81
Ability of the Encephalitic Arbovirus Semliki Forest Virus To Cross the Blood-Brain Barrier Is Determined by the Charge of the E2 Glycoprotein. J Virol (2015) 0.81
Loss of TLR3 aggravates CHIKV replication and pathology due to an altered virus-specific neutralizing antibody response. EMBO Mol Med (2014) 0.80
Kinetic and phenotypic analysis of CD8+ T cell responses after priming with alphavirus replicons and homologous or heterologous booster immunizations. J Virol (2014) 0.79
RNA Interference-Guided Targeting of Hepatitis C Virus Replication with Antisense Locked Nucleic Acid-Based Oligonucleotides Containing 8-oxo-dG Modifications. PLoS One (2015) 0.79
Obatoclax Inhibits Alphavirus Membrane Fusion by Neutralizing the Acidic Environment of Endocytic Compartments. Antimicrob Agents Chemother (2017) 0.78
Safe and Effective Treatment of Experimental Neuroblastoma and Glioblastoma Using Systemically Delivered Triple MicroRNA-Detargeted Oncolytic Semliki Forest Virus. Clin Cancer Res (2016) 0.78
Pentosan Polysulfate: a Novel Glycosaminoglycan-Like Molecule for Effective Treatment of Alphavirus-Induced Cartilage Destruction and Inflammatory Disease. J Virol (2015) 0.77
The Antiviral Alkaloid Berberine Reduces Chikungunya Virus-Induced Mitogen-Activated Protein Kinase Signaling. J Virol (2016) 0.77
Antigenic Variation of East/Central/South African and Asian Chikungunya Virus Genotypes in Neutralization by Immune Sera. PLoS Negl Trop Dis (2016) 0.76
Chikungunya virus infectivity, RNA replication and non-structural polyprotein processing depend on the nsP2 protease's active site cysteine residue. Sci Rep (2016) 0.75
Characterization of β-d-N(4)-Hydroxycytidine as a Novel Inhibitor of Chikungunya Virus. Antimicrob Agents Chemother (2017) 0.75
Mutation of the N-Terminal Region of Chikungunya Virus Capsid Protein: Implications for Vaccine Design. MBio (2017) 0.75
Attenuated and vectored vaccines protect nonhuman primates against Chikungunya virus. JCI Insight (2017) 0.75
Partially uncleaved alphavirus replicase forms spherule structures in the presence and absence of RNA template. J Virol (2017) 0.75
Correction for Utt et al., Mutations Conferring a Noncytotoxic Phenotype on Chikungunya Virus Replicons Compromise Enzymatic Properties of Nonstructural Protein 2. J Virol (2016) 0.75
SNAP-tagged Chikungunya Virus Replicons Improve Visualisation of Non-Structural Protein 3 by Fluorescence Microscopy. Sci Rep (2017) 0.75
Evaluation of a range of mammalian and mosquito cell lines for use in Chikungunya virus research. Sci Rep (2017) 0.75
Correction for Chen et al., Bindarit, an Inhibitor of Monocyte Chemotactic Protein Synthesis, Protects against Bone Loss Induced by Chikungunya Virus Infection. J Virol (2015) 0.75
Specific inhibition of NLRP3 in chikungunya disease reveals a role for inflammasomes in alphavirus-induced inflammation. Nat Microbiol (2017) 0.75